Pfizer Inc. agrees to pay $2M to resolve alleged compensation discrimination at New York City location

Here is a summary of the provided document:

Summary:

The U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) has entered into a conciliation agreement with Pfizer Inc. to resolve allegations of compensation discrimination against 86 female employees at Pfizer's New York City headquarters. The investigation found that Pfizer discriminated against the employees from January 2015 to December 2016, violating Executive Order 11246. To resolve the issue, Pfizer will pay $2 million in back wages and interest, conduct a compensation analysis, make salary adjustments if necessary, review and revise its overall compensation system, and provide enhanced training to managers. The agreement aims to bridge the gender wage gap and achieve pay equality for women in the workforce.